
stem-cell-biology

Many stem cell biologists plan to head to Montreal in July for the annual meeting of the ISSCR. The two program chairs Dr Fiona Doetsch from the University of Basel and Dr Nozomu Yachie from the University of British Columbia who has a lab at the University of Osaka, too, kindly gave a sneak-peek.
Many stem cell biologists plan to head to Montreal in July for the annual meeting of the ISSCR. The two program chairs Dr Fiona Doetsch from the University of Basel and Dr Nozomu Yachie from the University of British Columbia who has a lab at the University of Osaka, too, kindly gave a sneak-peek.
A ‘stemness checkpoint’ helps control stem cell identity A study published in Cell Research advances a central idea in stem cell biology by identifying a checkpoint that controls the identity of many different types of stem cells across develo
The stem cell niche is one of my favorite areas of research that I don’t actually work on directly. At least my lab hasn’t studied it much so far. My sense is that many scientists have favorite areas of research that they don’t actually study themselves. Do you have an area of research that particularly […] The post Weekly reads: the stem cell niche, tongue stem cells, autoimmune diseases appeare…
A new paper from George Church on trying to make human oocytes from stem cells seems notable for quite a few reasons. Something I’ve called stem cell IVF could be a future goal for Church’s work. Over the years, Church has also discussed possible heritable human gene editing, even for traits, as potentially a positive. […] The post Weekly reads: George Church egg paper, Chinese biotech, stem cell…
The Japanese stem cell and regenerative medicine oversight system is different than here in the U.S. and in Europe. Japan has had a more permissive approach to overseeing regenerative medicine. While most of the attention has focused on fairly legitimate regenerative biotechs and other sponsors in Japan, there are unproven stem cell clinics there. These […] The post Japanese stem cell clinic over…
It’s been an exhausting week for anyone who cares about the NIH and biomedical research, but in today’s weekly reads I want to talk about another kind of fatigue: stem cell exhaustion. Please subscribe to The Niche Before we get into that, I’d like to ask a favor: please subscribe to this site, The Niche. […] The post Weekly reads: stem cell exhaustion, Lineage Cell trial, Iowa AG wins vs. clinic…
As we look to 2026, what are the best regenerative medicine and stem cell journals? Is there a stem cell journal list out there? I seem to have the only comprehensive list. Who better than a stem cell biologist to put together this kind of list? Why is this important? Scientists need to know what […] The post List of regenerative medicine & stem cell journals appeared first on The Niche .
What might be some natural stem cell boosts? Should we be skeptical of such an idea? Boosting stem cells naturally Data suggests there could be ways to boost our stem cells naturally but it’s still early days in this line of research. How do we define a “stem cell boost”? I think of it as […] The post Six possible natural stem cell boosts appeared first on The Niche .
This story is part of our celebration of innovation in 2024. by Dana D’Amico, Connect to Science Dr. Jeanne Loring and the San Diego Zoo hope to revive the northern white rhinoceros and create a blueprint for stem cell-based conservation Marisa Korody arrived at the lab one day in 2021 to find The post Back from the Brink: Can Stem Cells Rewind Extinction? appeared first on Life in the Lab .
I often learn about new supposedly stem cell-related products like the LifeWave X39 Patch from readers. Sometimes such products are used by tens of thousands of people, in my view potentially raising risks to the public. If nothing else, people might be spending their money on something that isn’t worth it. As a stem cell biologist, […] The post LifeWave X39 stem cell patch story has holes appear…
What is a stem cell niche? It’s the home of stem cells. The stem cell niche is a fascinating environment. It has many constituents that impact stem cell behavior and even eventual stem cell transplant functions. In today’s weekly reads, we’ll start with the niche as there have been several interesting papers on this topic. The […] The post Weekly reads: stem cell niche & AI stumble on health appe…
This research analyzes several experiments observing the efficacy and safety of stem cell therapy on animal subjects and human fibroblasts with Parkinson’s disease. This paper also considers stem cell therapy’s ethical and financial implications, alongside the projected results, including increased survival rates and significant symptomatic relief of subjects.
The National Academy of Medicine elected a cohort of new members including three stem cell researchers. It’s great to see our field and these great scientists get recognition. The new NAM stem cell researchers include Sally Temple, Connie Eaves, and Tippie MacKenzie. Here’s a little bit about each of them. Dr. Temple is a stem cell biologist […] The post Weekly reads: NAM dubs 3 stem cell researc…
It’s always great to read about stem cell clinical trials that are looking encouraging. Stem cell clinical trials Proving a new therapy is safe and effective is so challenging. Remarkably, there are more than 9,300 stem cell clinical trials listed for a “stem cell” search on Clinicaltrials.gov. Of course, not all of these are actual […] The post Weekly reads: upbeat stem cell clinical trials upda…
22 August 2022 Sally Lowell is a developmental and stem cell biologist at the University of Edinburgh, UK. “My group is interested in how cells build embryos and tissues, and how we can control the behaviour of these cells in culture,” she explained. She is particularly interested in the local ‘conversations’ that cells have when […] The post Meet our Directors: Sally Lowell appeared first on The…
Stem cell biologist Jacob Hanna has a new startup called Renewal Bio. Its goal is to harvest cells or tissues from human embryo or fetus models for clinical use. I believe that their commercial ambitions have so far outstripped careful thought and discussion in the broader community of researchers. There are major risks here for […] The post ‘We don’t want to freak people out’: about that Jacob H…
The recent news of Vertex Pharma buying small stem cell biotech ViaCyte and Doug Melton moving to Vertex brought to mind an old stem cell biotech called Advanced Cell Technology (ACT) and its leader, stem cell biologist Dr. Robert Lanza. Years ago, big pharma firm Astellas bought ACT and Lanza moved to be a leader of regenerative […] The post In big shift Dr. Robert Lanza exits Astellas appeared …
Engineered biomaterials are increasingly used to expand and differentiate stem cells for technological and therapeutic applications. A major open question in the field is how the mechanical properties of material scaffolds regulate stem cell differentiation, especially in complex 3D geometries like those found in tissue. In a collaborative study published in Science Advances , the labs of Sanja…
research.ioSign up to keep scrolling
Create your feed subscriptions, save articles, keep scrolling.

